Administration of cyclooxygenase-2 inhibitor reduces joint inflammation but exacerbates osteopenia in IL-1α transgenic mice due to GM-CSF overproduction

Journal of Immunology

Volumn 179, Issue 1, 2007, Pages 639-646

  Niki, Yasuo ^a   Takaishi, Hironari ^a   Takito, Jiro ^a   Miyamoto, Takeshi ^a   Kosaki, Naoto ^a   Matsumoto, Hideo ^a   Toyama, Yoshiaki ^a   Tada, Norihiro ^b  

^a KEIO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; COLONY STIMULATING FACTOR 1; CYCLOOXYGENASE 2 INHIBITOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CELL DIFFERENTIATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; DETERIORATION; DISEASE EXACERBATION; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 34250817984     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.179.1.639     Document Type: Article

References (41)

1. Lipsky, P. E., P. A. Thompson, L. J. Rosenwasser, and C. A. Dinarello. 1983. The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocyte pyrogen. J. Immunol. 130: 2708-2714.
2. Dinarello, C. A., and S. M. Wolff. 1982. Molecular basis of fever in humans. Am. J. Med. 72: 799-819.
3. Gowen, M., D. D. Wood, E. J. Ihrie, M. K. B. McGuire, and R. G. G. Russell. 1983. An interleukin 1 like factor stimulates bone resorption in vitro. Nature 306: 378-380.
4. Strand, V., and A. F. Kavanaugh. 2004. The role of interleukin-1 in bone resorption in rheumatoid arthritis. Rheumatology 43(Suppl. 3): 10-16.
5. Assuma, R., T. Oates, D. Cochran, S. Amar, and D. T. Graves. 1998. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J. Immunol. 160: 403-409.
6. 2 production and decreasing OPG production by osteoblasts. Life Sci. 77: 615-626.
7. Kobayashi, K., N. Takahashi, E. Jimi, N. Udagawa, M. Takami, S. Kotake, N. Nakagawa, M. Kinosaki, K. Yamaguchi, N. Shima, et al. 2000. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191: 275-285.
8. Jimi, E., I. Nakamura, L. T. Duong, T. Ikebe, N. Takahashi, G. A. Rodan, and T. Suda. 1999. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp. Cell Res. 247: 84-93.
9. Boyce, B. F., T. B. Aufdemorte, I. R. Garrett, A. J. Yates, and G. R. Mundy. 1989. Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125: 1142-1150.
10. Sabatini, M., B. F. Boyce, T. Aufdemorte, L. Bonewald, and G. R. Mundy. 1988. Infusions recombinant human interleukin-1alpha; and 1β cause hypercalcemia in normal mice. Proc. Natl. Acad. Sci. USA 85: 5235-5239.
11. Niki, Y., H. Yamada, S. Seki, T. Kikuch, H. Takaishi, Y. Toyama, K. Fujikawa, and N. Tada. 2001. Macrophage- and neutrophil-dominant arthritis in human IL-1α transgenic mice. J. Clin. Invest. 107: 1127-1135.
12. Niki, Y., H. Yamada, T. Kikuchi, Y. Toyama, H. Matsumoto, K. Fujikawa, and N. Tada. 2004. Membrane-associated IL-1 contributes to chronic synovitis and cartilage destruction in human IL-1α transgenic mice. J. Immunol. 172: 577-584.
13. Miyamoto, T., O. Ohneda, F. Arai, K. Iwamoto, S. Okada, K. Takagi, D. M. Anderson, and T. Suda. 2001. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98: 2544-2554.
14. Day, C. J., M. S. Kim, S. R. J. Stephens, W. E. Simcock, C. J. Aitken, G. C. Nicholson, and N. A. Morrison. 2004. Gene array identification of osteoclast gene: differential inhibition of osteoclastogenesis by cyclosporine A and granulocyte macrophage colony stimulating factor. J. Cell Biochem. 91: 303-315.
15. Aoki, Y., S. Ichimura, T. Kikuchi, Y. Yoshihara, M. Kogawa, N. Tada, K. Nemoto, and K. Fujikawa. 2005. Overexpression of the human interleukin 1α gene causes osteopenia in mice. J. Rheumatol. 32: 320-324.
16. Ochi, T., and T. Goto. 2000. Anti-inflammatory effect of FR140423, a novel selective cyclo-oxygenase-2 inhibitor, in rat adjuvant arthritis without gastrointestinal side effects. J. Pharm. Pharmacol. 52: 553-560.
17. Ochi, T., and T. Goto. 2001. Anti-inflammatory effect of a novel selective cyclooxygenase-2 inhibitor, FR140423, on type II collagen-induced arthritis in Lewis rats. Prostag. Lipid Mediat. 66: 317-327.
18. Ochi, T., Y. Ohkubo, and S. Mutoh. 2003. Role of cyclooxygenase-2, but not cyclooxygenase-1, on type II collagen-induced arthritis in DBA/1J mice. Biochem. Pharm. 66: 1055-1060.
19. Noguchi, M., A. Kimoto, S. Kobayashi, T. Yoshino, K. Miyata, and M. Sasamata. 2005. Effect of celecoxib, a cyclooxygenase-2 inhibitor, on the pathophysiology of adjuvant arthritis in rat. Eur. J. Pharmacol. 513: 229-235.
20. Igarashi, K., J. T. Woo, and P. H. Stern. 2002. Effects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in vitro. Biochem. Pharm. 63: 523-532.
21. Okada, Y., J. A. Lorenzo, A. M. Freeman, M. Tomita, S. G. Morham, L. G. Raisz, and C. C. Pilbeam. 2000. Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J. Clin. Invest. 105: 823-832.
22. 2 in vivo and in vitro. Bone 34: 157-162.
23. 2 production. Bone 36: 267-275.
24. Min, Y. K., Y. Rao, Y. Okada, L. G. Raisz, and C. C. Pilbeam. 1998. Regulation of prostaglandin G/H synthase-2 expression by interleukin-1 in human osteoblast-like cells. J. Bone Miner. Res. 13: 1066-1075.
25. Penning, T. D., J. J. Tally, S. R. Bertenshaw, J. S. Carter, P. W. Collins, S. Docter, M. J. Graneto, L. F. Lee, J. W. Malecha, and J. M. Miyashiro. 1997. Synthesis and biological evaluation of the 1,5-diarylpyrasole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3- (trifluoromethyl)-pyrazol-1-yl] benzenesulfonamide (SC-58635, celecoxib). J. Med. Chem. 40: 1347-1365.
26. Suda, T., E. Jimi, I. Nakamura, and N. Takahashi. 1997. Role of la, 25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol. 282: 223-227.
27. Arai, F., T. Miyamoto, O. Ohneda, T. Inada, T. Sudo, K. Brasel, T. Miyata, D. M. Anderson, and T. Suda. 1999. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J. Exp. Med. 190: 1741-1754.
28. + progenitors in vitro. J. Immunol. 174: 2552-2562.
29. Takeda, M., I. Yamamoto, and R. Morita. 1994. Chronic intramedullary infusion of IL-1α increases bone mineral content in rats. Calcif. Tissue Int. 55: 103-108.
30. 2. Calcif. Tissue Int. 50: 80-87.
31. 2 on production of new cancellous bone in the axial skeleton of ovariectomized rats. Bone 11: 103-113.
32. 2 in young rats increases the osteogenic capacity of bone marrow. Bone 20: 521-526.
33. 2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro. J. Endocrinol. 168: 131-139.
34. Okada, Y., M. Tomita, G. Gronowicz, H. Kawaguchi, J. Sohn, Y. Tanaka, I. Morimoto, T. Nakamura, L. Raisz, and C. Pilbeam. 2005. Effects of cyclooxygenase-2 gene disruption on osteoblastic function. J. Bone Miner. Res. 15(suppl.): 217(Abstr.).
35. Nakai, K., S. Tanaka, A. Sakai, M. Nagashima, M. Tanaka, H. Otomo, and T. Nakamura. 2006. Cyclooxygenase-2 selective inhibition suppresses restoration of tibial trabecular bone formation in association with restriction of osteoblast maturation in skeletal reloading after hind limb elevation of mice. Bone 39: 83-92.
36. Myers, L. K., A. H. Kang, A. E. Postlethwaite, E. F. Rosloniec, S. G. Morham, B. V. Shlopov, S. Goorha, and L. R. Ballou. 2000. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum. 43: 2687-2693.
37. Arron, J. Y., and Y. Choi. 2000. Bone versus immune system. Nature 408: 535-536.
38. Kong, Y. Y., U. Feige, I. Sarosi, B. Bolon, A. Tafuri, S. Morony, C. Capparelli, J. Li, R. Elliott, S. McCabe, et al. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304-309.
39. Sato, K., A. Suematsu, K. Okamoto, A. Yamaguchi, Y. Morishita, Y. Kadono, S. Tanaka, T. Kodama, S. Akira, Y. Iwakura, et al. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203: 2673-2682.
40. Lubberts, E., L. A. Joosten, B. Oppers, L. van den Bersselaar, C. J. Coenen-de Roo, J. K. Kolls, P. Schwarzenberger, F. A. van de Loo, and W. B. van den Berg. 2001. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J. Immunol. 167: 1004-1013.
41. Sutton, C., C. Brereton, B. Keogh, K. H. Mills, and E. C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL- 17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203: 1685-1691.